Jul 2026· Animal Models and Experimental Medicine· Vol 9, pp. 1613 - 1632· 0 citations· 46 references
Medicine
TL;DR
This data indicates that suppression of dopaminergic neurons in the substantia nigra results in striatal dopamine depletion and motor dysfunction in Parkinson's disease, and further studies are needed to establish a specific mechanism behind this phenomenon.
Abstract
Parkinson's disease (PD) is a neurodegenerative disorder characterized by progressive degeneration of midbrain substantia nigra dopaminergic neurons, resulting in striatal dopamine depletion and motor dysfunction. While this pathological cascade is well‐established, its underlying mechanisms remain elusive.
Astrocyte dysfunction is central to Alzheimer's disease (AD), yet expression patterns of astrocytic markers remain poorly defined. We measured Aquaporin‐4 (AQP4) and glial fibrillary acidic protein (GFAP) in post‐mortem frontal cortex of AD patients and controls across BrainNet Europe (BNE) stages.
Harry Alexopoulos, X. Louka, E. D. de Natale et al.· Alzheimer's & Dementia· 0 citations
This scientific commentary refers to ‘Data-driven modelling of tau pathology reveals distinct progressive supranuclear palsy subtypes’ by Cullinane et al. (https://doi.org/10.1093/brain/awag131).
D. Thal, J. Schaeverbeke· Brain : a journal of neurolo...· 0 citations
Dysfunctional microRNAs and GABAergic interneurons are features of Alzheimer's disease (AD). The role of neuronal microRNA155 (miR155), elevated in both AD and Down syndrome (DS), remains unknown.
Using human induced pluripotent stem cells (hiPSCs)‐derived neurons, human induced pluripotent stem cells were assayed how reducing gene expression of MSN and CD44 affected amyloid beta secretion, tau phosphorylation, and transcriptional state.
Eiden H. Brewer, Charles A. Williams, Gregory A. Cary et al.· Alzheimer's & Dementia· 0 citations
Alzheimer's disease (AD) features amyloid beta (Aβ) plaques and tau tangles, yet how their coexistence reshapes brain transcriptomic programs remains unclear.
Jung Hyun Park, Byungwook Kim, Mamun Md Al‐Amin et al.· Alzheimer's & Dementia· 0 citations